Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

We are reimagining clinical trials

Vial was founded on a mission to reimagine clinical trials and deliver faster and more efficient trials for sponsors

35+

Clinical Research Sites

750+

Trials Completed

6

Therapeutic Areas

Vial's vision
is to empower scientists to cure all human disease.

Vial is a next-generation tech-enabled CRO that delivers faster and 50%+ cheaper trials through end-to-end technology platform.

Our team is a marriage of ClinOps leaders with over 150 years of experience at CROs and a best-in-class team of Engineers, Product Managers and Designs from Silicon Valley. Together, our team has built a technology platform to deliver on a generational opportunity to make trials radically more efficient.

Meet our Leadership Team

Clinical Operations Expertise meets product minds from Silicon Valley

Simon Burns

Simon Burns

Co-founder & Chief Executive Officer

Andrew Brackin

Andrew Brackin

Co-founder & Chief Revenue Officer

Wendy Pinson

Wendy Pinson

Director of Oncology

William MacInnis

Will MacInnis

VP Finance

Ananya Shah

Ananya Shah

VP Operations

Dan Gallagher

Head of Business Development

Scientific Advisory Board

Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.

Dr Guru Sonpavde

Dr. Guru Sonpavde

Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard
Medical School

Dr Neeraj Agarwal

Dr. Neeraj Agarwal

Professor of Medicine and Presidential Endowed Chair of Cancer Research
at the Huntsman Cancer Institute, University of Utah

Dr.-Arshad-Khanani-MD-

Dr. Arshad Khanani

Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates

Dr. Mark Lebwohl

Dr. Mark Lebwohl

Waldman Professor and Chairman
of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the
Mount Sinai Hospital in New York City

Dr. Luke Nordquist

Dr. Luke Nordquist

CEO at Urology Cancer Center and XCancer Research

Dr Arvind Chaudhry

Dr. Arvind Chaudhry

Director of Summit Cancer Centers, Medical Oncologist

Dr Nancy Holekamp

Dr. Nancy Holekamp

Director of Retina Services
at the Pepose Vision Institute

Dr. David Pariser

Dr. David Pariser

Senior physician of Pariser Dermatology Specialist and Principal Investigator

Dr Arati Rao

Dr. Arati Rao

Head of Clinical Development at PACT Pharma

Dr. Antoni Ribas

Dr. Antoni Ribas

Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)

Merola_Joseph

Dr. Joseph Merola

Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School

Jonathan Zung

Dr. Jonathan Zung

Chief Development Officer at Evelo Biosciences

Dr. Nathan Pennell

Professor of Medicine and Director of the Lung Cancer Medical Oncology Program at the Cleveland Clinic Taussig Cancer Institute.

Dr. Paul Karpecki

Dr. Paul Karpecki

Director of Corneal Services at Kentucky Eye Institute and Faculty Associate Professor at the University of Pikeville, Kentucky, College of Optometry.

Interested in receiving a proposal from Vial?
Leave us a message and some of your contact info and
we’ll be in touch with you shortly.